Bibliography
- LEIBOWITZ HM, KRUEGER DE, MAUNDER LR et al.: The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv. Ophthalmol. (1980) 24:335-610.
- KLEIN BE, KLEIN R: Cataracts and macular degeneration in older Americans. Arch. Ophthalmol. (1982) 100:571-573.
- MARTINEZ GS, CAMPBELL AJ, REINKEN J, ALLAN BC: Prevalence of ocular disease in a population study of subjects 65 years old and older. Am. J. Ophthalmol. (1982) 94:181-189.
- GIBSON JM, ROSENTHAL AR, LAVERY J: A study of the prevalence of eye disease in the elderly in an English community. Trans. Ophthalmol. Soc. UK (1985) 104:196-203.
- VINDING T: Age-related macular degeneration. Macular changes, prevalence and sex ratio. An epidemiological study of 1000 aged individuals. Acta Ophthalmol. (Copenhagen) (1989) 67:609-616.
- BRESSLER NM, BRESSLER SB, WEST SK, FINE SL, TAYLOR HR: The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch. Ophthalmol. (1989) 107:847-852.
- KLEIN R, KLEIN BE, LINTON KL: Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology (1992) 99:933-943.
- VINGERLING JR, DIELEMANS I, HOFMAN A et al.: The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 102:205-210.
- HAWKINS BS, BIRD A, KLEIN R, WEST SK: Epidemiology of age-related macular degeneration. Mol. Vis. (1999) 5:26.
- DAVIS MD, HILLER R, MAGLI YL et al.: Prognosis for life in patients with diabetes: relation to severity of retinopathy. Trans. Am. Ophthalmol. Soc. (1979) 77:144-170.
- PODGOR MJ, CASSEL GH, KANNEL WB: Lens changes and survival in a population-based study. N. Engl. J. Med. (1985) 313:1438-1444.
- KLEIN R, KLEIN BE, MOSS SE, DAVIS MD, DEMETS DL: The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch. Ophthalmol. (1984) 102:520-526.
- KLEIN R, MOSS SE, KLEIN BE, DEMETS DL: Relation of ocular and systemic factors to survival in diabetes. Arch. Intern. Med. (1989) 149:266-272.
- KLEIN R, KLEIN BE, MOSS SE: Age-related eye disease and survival. The Beaver Dam Eye Study. Arch. Ophthalmol. (1995) 113:333-339.
- COLEMAN AL: Glaucoma. Lancet (1999) 354:1803-1810.
- WEST SK: Looking forward to 20/20: a focus on the epidemiology of eye diseases. Epidemiol. Rev. (2000) 22:64-70.
- HOYNG PF, VAN BEEK LM: Pharmacological therapy for glaucoma: a review. Drugs (2000) 59:411-434.
- WEIH LM, VANNEWKIRK MR, MCCARTY CA, TAYLOR HR: Age-specific causes of bilateral visual impairment. Arch. Ophthalmol. (2000) 118:264-269.
- DRYJA TP, LI T: Molecular genetics of retinitis pigmentosa. Hum. Mol. Genet. (1995) 4:1739-1743.
- HOLT IJ, HARDING AE, PETTY RK, MORGAN-HUGHES JA: A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. (1990) 46:428-433.
- NARCISI TM, SHOULDERS CC, CHESTER SA et al.: Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia. Am. J. Hum. Genet. (1995) 57:1298-1310.
- MEINDL A, DRY K, HERRMANN K et al.: A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nat. Genet. (1996) 13:35-42.
- CEDARBAUM JM: The pharmacokinetics of subcutaneously administered recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis: relation to parameters of the acute-phase response. the ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. Clin. Neuropharmacol. (1995) 18:500-514.
- CEDARBAUM JM: A Phase I study of recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis. The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. Clin. Neuropharmacol. (1995) 18:515-532.
- EMERICH DF, LINDNER MD, WINN SR, CHEN EY, FRYDEL BR, KORDOWER JH: Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington’s disease. J. Neurosci. (1996) 16:5168-5181.
- EMERICH DF, WINN SR, HANTRAYE PM et al.: Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington’s disease. Nature (1997) 386:395-399.
- EMERICH DF, PLONE M, FRANCIS J, FRYDEL BR, WINN SR, LINDNER MD: Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts. Brain Res. (1996) 736:99-110.
- TSENG JL, BAETGE EE, ZURN AD, AEBISCHER P: GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. J. Neurosci. (1997) 17:325-333.
- EMERICH DF, HAMMANG JP, BAETGE EE, WINN SR: Implantation of polymer-encapsulated human nerve growth factor- secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum. Exp. Neurol. (1994) 130:141-150.
- EMERICH DF, WINN SR, HARPER J, HAMMANG JP, BAETGE EE, KORDOWER JH: Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. J. Comp. Neurol. (1994) 349:148-164.
- KORDOWER JH, WINN SR, LIU YT et al.: The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc. Natl. Acad. Sci. USA (1994) 91:10898-10902.
- LINDNER MD, KEARNS CE, WINN SR, FRYDEL B, EMERICH DF: Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged rats. Cell Transplant. (1996) 5:205-223.
- HOANE MR, PURI KD, XU L et al.: Mammalian-cell-produced neurturin (NTN) is more potent than purified Escherichia coli-produced NTN. Exp. Neurol. (2000) 162:189-193.
- TAO W, WEN R, GODDARD MB et al.: Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. (2002) 43:3292-3298.
- FAKTOROVICH EG, STEINBERG RH, YASUMURA D, MATTHES MT, LAVAIL MM: Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature (1990) 347:83-86.
- LAVAIL MM, UNOKI K, YASUMURA D, MATTHES MT, YANCOPOULOS GD, STEINBERG RH: Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc. Natl. Acad. Sci. USA (1992) 89:11249-11253.
- UNOKI K, OHBA N, ARIMURA H, MURAMATSU H, MURAMATSU T: Rescue of photoreceptors from the damaging effects of constant light by midkine, a retinoic acid-responsive gene product. Invest. Ophthalmol. Vis. Sci. (1994) 35:4063-4068.
- LAVAIL MM, YASUMURA D, MATTHES MT et al.: Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest. Ophthalmol. Vis. Sci. (1998) 39:592-602.
- HAUSWIRTH WW, LI Q, RAISLER B et al.: Range of retinal diseases potentially treatable by AAV-vectored gene therapy. Novartis Found. Symp. (2004) 255:179-188, discussion 188-194.
- LAWRENCE JM, KEEGAN DJ, MUIR EM et al.: Transplantation of Schwann cell line clones secreting GDNF or BDNF into the retinas of dystrophic Royal College of Surgeons rats. Invest. Ophthalmol. Vis. Sci. (2004) 45:267-274.
- MACHIDA S, CHAUDHRY P, SHINOHARA T et al.: Lens epithelium-derived growth factor promotes photoreceptor survival in light-damaged and RCS rats. Invest. Ophthalmol. Vis. Sci. (2001) 42:1087-1095.
- NAKAMURA M, SINGH DP, KUBO E, CHYLACK LT JR, SHINOHARA T: LEDGF: Survival of embryonic chick retinal photoreceptor cells. Invest. Ophthalmol. Vis. Sci. (2000) 41:1168-1175.
- SONG Y, ZHAO L, TAO W, LATIES AM, LUO Z, WEN R: Photoreceptor protection by cardiotrophin-1 in transgenic rats with the rhodopsin mutation s334ter. Invest. Ophthalmol. Vis. Sci. (2003) 44:4069-4075.
- LIU C, LI Y, PENG M, LATIES AM, WEN R: Activation of caspase-3 in the retina of transgenic rats with the rhodopsin mutation s334ter during photoreceptor degeneration. J. Neurosci. (1999) 19:4778-4785.
- AGUIRRE GF, DEBORA F, LOLLEY R et al.: Retinal degenerations in the dog III abnormal cyclic nucleotide metabolism in rod-cone dysplasia. Exp. Eye Res. (1982) 35:625-642.
- RAY K, BALDWIN VJ, ACLAND GM, BLANTON SH, AGUIRRE GD: Cosegregation of codon 807 mutation of the canine rod cGMP phosphodiesterase beta gene and rcd1. Invest. Ophthalmol. Vis. Sci. (1994) 35:4291-4299.
- THANOS CG, BELL W, O’ROURKE P et al.: Sustained secretion of ciliary neurotrphic factor to the vitrous, using the encapsulated cell therapy-based NT-501 intraocular device. Tissue Eng. (2004) 10:1617-1622.
- SIEVING PA, CARUSO RC, TAO W et al.: CNTF for human retinal neurodegeneration: Phase I study of ciliary neurotrophic factor delivered by encapsulated cell technology implants for retinitis pigmentosa. Proc. Natl. Acad. Sci. USA (2006) 103(10):3896-3901.
- WU WC, LAI CC, CHEN SL et al.: GDNF gene therapy attenuates retinal ischemic injuries in rats. Mol. Vis. (2004) 10:93-102.
- LINDQVIST N, PEINADO-RAMONNP P, VIDAL-SANZ M, HALLBOOK F: GDNF, Ret, GFRalpha1 and 2 in the adult rat retino-tectal system after optic nerve transection. Exp. Neurol. (2004) 187:487-499.
- MEY J, THANOS S: Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res. (1993) 602:304-317.
- KO ML, HU DN, RITCH R, SHARMA SC, CHEN CF: Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats. Neurosci. Lett. (2001) 305:139-142.
- WATANABE M, FUKUDA Y: Survival and axonal regeneration of retinal ganglion cells in adult cats. Prog. Retin. Eye Res. (2002) 21:529-553.
- VAN ADEL BA, KOSTIC C, DEGLON N, BALL AK, ARSENIJEVIC Y: Delivery of ciliary neurotrophic factor via lentiviral-mediated transfer protects axotomized retinal ganglion cells for an extended period of time. Hum. Gene Ther. (2003) 14:103-115.
- JI JZ, ELYAMAN W, YIP HK et al.: CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway. Eur. J. Neurosci. (2004) 19:265-272.
- RIZZO LV, XU H, CHAN CC, WIGGERT B, CASPI RR: IL-10 has a protective role in experimental autoimmune uveoretinitis. Int. Immunol. (1998) 10:807-814.
- ROSENBAUM JT, ANGELL E: Paradoxical effects of IL-10 in endotoxin-induced uveitis. J. Immunol. (1995) 155:4090-4094.
- DE KOZAK Y, THILLAYE-GOLDENBERG B, NAUD MC, DA COSTA AV, AURIAULT C, VERWAERDE C: Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene. Clin. Exp. Immunol. (2002) 130:212-223.